Hyperlipidemia; Mixed Clinical Trials
2 recruiting trials for Hyperlipidemia; Mixed. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
1
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGPhase 3NCT06568471
A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia
This randomized study is to assess LDL-C reductions at Week 12 with monthly (Q4W \[≤31 days\]) dosing of HST101 (lerodalcibep) 300 mg administered subcutaneously (SC) compared to...
Sponsor: Hasten Biopharmaceutical Co., Ltd.Enrolling: 21018 locations
RECRUITINGPhase 1 / Phase 2NCT07223658
Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia
Study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD), and effects on low-density lipoprotein cholesterol (LDL-C) and triglycerides (TGs) of...
Sponsor: Arrowhead PharmaceuticalsEnrolling: 781 location